In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
The version of belzutifan produced by Lucius Pharmaceuticals is a more cost-effe···【more】
Release date:2026-02-06Recommended:93
Belzutifan is an oral targeted drug of the hypoxia-inducible factor-2α (HIF-2α) ···【more】
Release date:2026-02-06Recommended:110
Belzutifan is a hypoxia-inducible factor (HIF) inhibitor. It exerts its effect b···【more】
Release date:2026-02-06Recommended:103
Doctors should conduct regular follow-ups to evaluate the efficacy of the medica···【more】
Release date:2026-02-05Recommended:56
After administration, necessary therapeutic effects may occur, and adverse react···【more】
Release date:2026-02-05Recommended:63
Some medications are absolutely contraindicated for combined use. For other medi···【more】
Release date:2026-02-05Recommended:81
Cabozantinib is a non-chemotherapy prescription medication classified as a tyros···【more】
Release date:2026-02-05Recommended:97
Patients should take pirfenidone with meals at a fixed time every day to reduce ···【more】
Release date:2026-02-04Recommended:115
The most common side effects of pirfenidone include upper respiratory tract infe···【more】
Release date:2026-02-04Recommended:90
Pirfenidone is an oral antifibrotic medication primarily used for the treatment ···【more】
Release date:2026-02-04Recommended:99
The safety of pirfenidone has been evaluated in more than 1,400 subjects, of who···【more】
Release date:2026-02-04Recommended:105
Nintedanib is a multi-targeted tyrosine kinase inhibitor; it can reduce the acti···【more】
Release date:2026-02-03Recommended:88